Develops biosensing platforms that merge optofluidics, optical/quantum spectroscopy, and data‑centric modeling. Full‑spectrum, multiresonance analyses with machine learning improve precision, enabling compact, automated assays for rapid, low‑volume, point‑of‑care diagnostics.